NAMI Pharma Marketing Blog Grassley
View PDF of blog article here
Similar Posts
Which is it—51 or 186 deaths linked to ADHD drugs?
Children have been dying from exposure to psychostimulant drugs as the FDA looked the other way:
Infomail Archive 2004
Infomail 2004 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Dec 31: FDA to review “missing” drug company documents Dec 30: Family of Woman Killed by AIDS Drug Test Sues Doctors, Manufacturer Dec 30: Doctors, Too, Ask: Is This Drug Right? Dec 29: Bill would shield…
Showdown Looms in Congress Over Drug Advertising on TV
The FDA is salivating in expectation of increased funding from the drug industry–ostensibly to speed up the reviewing process for TV ads.
Journals Must Exercise Their Authority as Gatekeepers
The harm done by journals’ failure to protect the integrity of science can hardly be overstated.
Article
Sen Grassley to Offer Mandatory Drug Data Registry Bill Fri, 10 Dec 2004 AHRP applauds Senator Chuck Grassley for spearheading legislation that will require pharmaceutical companies to register ALL drug trials and report their results in a public database. Given the record of deception and concealment of adverse data, anything…
FDA acknowledges failure to act as defibrillator malfunction increased
FDA acknowledges failure to act as defibrillator malfunction increased: 4,225 failed between 2000–2003 Sat, 17 Sep 2005 The Washington Post reports that the number of failed heart defibrillators is increasing: “William H. Maisel, the Harvard Medical School physician who conducted the FDA study, said the increase is significant and contrasts…